To see the other types of publications on this topic, follow the link: Ovarios - Tumores.

Journal articles on the topic 'Ovarios - Tumores'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Ovarios - Tumores.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Otero, Jorge Miguel, Fernando Arias, Eduardo Londoño, et al. "Características patológicas y moleculares del pseudomixoma peritoneal (ONCOLGroup)." Revista Colombiana de Hematología y Oncología 1, no. 1 (2012): 52–59. http://dx.doi.org/10.51643/22562915.288.

Full text
Abstract:
El pseudomixoma peritoneal (PMP) es una condición patológica pobremente entendida, caracterizada por la presencia de ascitis mucinosa relacionada a siembras peritoneales multifocales. Múltiples estudios histopatológicos que incluyeron inmunohistoquímica han sugerido que la mayoría de los PMP, si no todos los casos, derivan de adenomas mucinosos del apéndice más que de lesiones primarias del ovario. Pocos estudios que han evaluado la biología molecular y la genética del PMP se han reportado recientemente; sin embargo, estos trabajos solo han analizado un pequeño número de casos, incluyendo mues
APA, Harvard, Vancouver, ISO, and other styles
2

Samame Boggio, Guido. "Tumores funcionantes feminizantes de ovario." Revista Peruana de Ginecología y Obstetricia 11, no. 3 (2015): 249–54. http://dx.doi.org/10.31403/rpgo.v11i1270.

Full text
Abstract:
He presentado un estudio estadístico del Pabellón N° 5, 2da. Sala, realizado en 32 años; habiendo encontrado 15,480 ginecópatas, de las cuales presentaron 1,480 tumores del ovario; de éstos, 2 presentaron tumores a la teca y 9 a tumores de las células de la granulosa. La frecuencia de tumores de ovarios ha sido de 9,2 % y la de tumores a células de la granulosa a 0,62 % y 0,13% la de los tumores de la teca. Referente a la edad, debemos decir que el 60% correspondían a la edad genital activa y el resto a la menopausia. En relación a la malignidad, debemos decir que la mayoría de ellas no presen
APA, Harvard, Vancouver, ISO, and other styles
3

Mori Chávez, Pablo. "Estudios experimentales sobre implantación ovárica de algunos tumores transplantables de ratas." Revista Peruana de Ginecología y Obstetricia 1, no. 2 (2015): 25–41. http://dx.doi.org/10.31403/rpgo.v1i898.

Full text
Abstract:
En una publicación anterior sobre un carcinoma ovárico de rata se mostró su predilección para implantar el ovario cuando era trasplantado intrsperitonealmente. Los experimentos referidos aquí amplían el trabajo y muestran que otros tres tumores, además del carcinoma ovárico, eran capaces de implantarse y crecer en los ovarios. Se ha considerado y discutido la mayor incidencia de implantes ováricos del carcinoma ovárico en los transplantes intraperitoneales, llegando a la conclusión de que esta habilidad provenía de su mayor malignidad y de la mayor liberación de células vivas capaces de atrave
APA, Harvard, Vancouver, ISO, and other styles
4

Esteves F., Augusto. "Ovario quístico a pediculo torcido en la infancia." Revista Peruana de Ginecología y Obstetricia 12, no. 3 (2015): 373–77. http://dx.doi.org/10.31403/rpgo.v12i885.

Full text
Abstract:
Se hace una revisión de la literatura concerniente a tumores de ovario en la niñez. El dolor abdominal bajo, unilateral, en la infancia, con una historia de previos ataques paroxísticos de dolor, es altamente sugestivo de un tumor de ovario a pedículo torcido. La exploración quirúrgica es recomendada en estos casos. Semejante política facilitaría al cirujano preservar muchos ovarios conteniendo quistes no-neoplásicos, con una resección de ellos, antes que el ovario sea destruido por una estrangulación completa. Ovarios quísticos con torsión del pedículo en los niños, es una condición que usual
APA, Harvard, Vancouver, ISO, and other styles
5

Reyna-Villasmil, Eduardo, Duly Torres-Cepeda, and Martha Rondon-Tapia. "Hiperreacción luteínica durante el tercer trimestre del embarazo. Reporte de caso." Revista Peruana de Ginecología y Obstetricia 66, no. 1 (2020): 95–99. http://dx.doi.org/10.31403/rpgo.v66i2239.

Full text
Abstract:
La hiperreacción luteínica es una entidad poco frecuente del embarazo, que se caracteriza por aumento bilateral y funcional de los ovarios con presencia de quistes de paredes finas. Varias hipótesis sugieren que es causada por el aumento de las concentraciones o la sensibilidad ovárica a la gonadotropina coriónica. La mayoría no presenta síntomas o complicaciones del embarazo, y el diagnóstico se realiza en forma accidental por ecografía de rutina. Es una condición benigna rara, suele autolimitarse y se resuelve espontáneamente después del parto. Sin embargo, a veces no pueden ser diferenciado
APA, Harvard, Vancouver, ISO, and other styles
6

Bernal-Mesa, Jorge Alberto, Juan Jacobo Del Valle-Saavedra, and Federico López-Uribe. "Quistes mesoteliales benignos con posible origen en las trompas de Falopio resecados por laparotomía." Revista Colombiana de Cirugía 36, no. 4 (2021): 726–31. http://dx.doi.org/10.30944/20117582.738.

Full text
Abstract:
Introducción. Los quistes mesoteliales benignos son una entidad poco frecuente, que ocurren especialmente en mujeres en edad reproductiva. Se deben a una proliferación anómala del mesotelio que puede ser originada en varias estructuras intraabdominales e inicialmente es asintomática.
 Caso clínico. Se presenta el caso de una mujer de 20 años con un cuadro sugestivo de neoplasia maligna, en quien se confirmó el diagnóstico de quiste mesotelial originado en la trompa de Falopio derecha. Se realizó tratamiento quirúrgico exitoso.
 Discusión. A pesar de la estrecha relación de esta entid
APA, Harvard, Vancouver, ISO, and other styles
7

Larrea, Agustina Lucila, Vicente Ricardo González, Pablo Knoblovits, and Santiago José Gil. "Virilización y enfermedad metabólica en mujer postmenopáusica relacionado a hiperplasia e hipertecosis ovárica." Revista de la Facultad de Ciencias Médicas de Córdoba 78, no. 2 (2021): 193–96. http://dx.doi.org/10.31053/1853.0605.v78.n2.32136.

Full text
Abstract:
Durante la transición menopáusica pueden aparecer signos clínicos leves de hiperandrogenismo, como parte del proceso de envejecimiento normal, pero el desarrollo de virilización franca sugiere una fuente específica de exceso de andrógenos debiendo descartar la presencia de tumores secretores de andrógenos tanto a nivel adrenal como ovárico.
 Se presenta un caso de una mujer de 51 años postmenopáusica con signos de virilización de 12 meses de evolución, asociado a antecedente personal de diabetes tipo 2 e hipertensión arterial, de mal manejo en el último año. Las pruebas de laboratorio mos
APA, Harvard, Vancouver, ISO, and other styles
8

Valson, H., Satish Arakeri, Dally Maria Davis, and Divya S. "Retrospective study of tumor and tumor like conditions of ovary from a rural hospital in Kerala." International Journal of Reproduction, Contraception, Obstetrics and Gynecology 6, no. 8 (2017): 3275. http://dx.doi.org/10.18203/2320-1770.ijrcog20173074.

Full text
Abstract:
Background: Ovarian tumor and tumor like conditions are seen in women from early childhood to post-menopausal age. The ovaries are a pair of female sex glands responsible for the germ cell maturation, storage and release; cyclically. It also plays an important role in steroidogenesis. The ovaries are a totipotential structure and hence, neoplasms from all 3 germinal layers can be seen arising from it and manifesting clinically as ovarian tumors and tumor like conditions with its occurrence more during the late reproductive life. Ovarian tumors represent about 30% of all cancers of the female g
APA, Harvard, Vancouver, ISO, and other styles
9

Paula, Leila C. P. de, Vanessa L. Zen, and Mauro A. Czepielewski. "Puberdade precoce associada a tumor misto ovariano (células germinativas- estroma-cordão sexual): aspectos clínicos, diagnósticos e manejo de um caso." Arquivos Brasileiros de Endocrinologia & Metabologia 49, no. 5 (2005): 776–83. http://dx.doi.org/10.1590/s0004-27302005000500018.

Full text
Abstract:
Os tumores de estroma ovariano são responsáveis por 5 a 8% dos tumores ovarianos. Sua manifestação clínica inicial mais comum em meninas pré-puberais é o desenvolvimento de puberdade precoce. Neste artigo discutimos o caso de uma menina de 7 anos e 2 meses com tumor de estroma ovariano do tipo misto - cordões-sexuais-células germinativas -, cuja manifestação inicial foi puberdade precoce isossexual, de evolução rápida e progressiva. Os níveis séricos de testosterona, estradiol e 17alfaOH-progesterona encontravam-se elevados. A ecografia pélvica-abdominal demonstrou massa anexal direita. Salpin
APA, Harvard, Vancouver, ISO, and other styles
10

Riccardi, Elena, Valeria Greco, Sara Verganti, and Mario Finazzi. "Immunohistochemical Diagnosis of Canine Ovarian Epithelial and Granulosa Cell Tumors." Journal of Veterinary Diagnostic Investigation 19, no. 4 (2007): 431–35. http://dx.doi.org/10.1177/104063870701900418.

Full text
Abstract:
In humans and canines, the morphology of granulosa cell tumors is extremely variable and causes diagnostic difficulties. In human pathology, immunohistochemistry has been widely used for the diagnosis of granulosa cell tumors, whereas, limited studies are present in canine species. The aim of this study was to investigate the expression of cytokeratins, vimentin, and inhibin-α in canine normal ovaries, epithelial ovarian tumors, and granulosa cell tumors to establish an immunohistochemical panel for the differential diagnosis of ovarian tumors. Formalin-fixed, paraffin-embedded tissue sections
APA, Harvard, Vancouver, ISO, and other styles
11

Parmar, Riddhi, Mansi Davda, Navin Patel, and Keval Arvindbhai Patel. "Krukenberg tumor in a young female arising from a primary adenocarcinoma of stomach: a case report." International Journal of Reproduction, Contraception, Obstetrics and Gynecology 10, no. 6 (2021): 2523. http://dx.doi.org/10.18203/2320-1770.ijrcog20212209.

Full text
Abstract:
Krukenberg tumor is a malignancy of ovary that metastasizes from a primary site. Krukenberg tumors are uncommon and account for less than 2% of all ovarian tumors. It is usually a bilateral involvement of ovaries from the metastatic deposit from adenocarcinoma of the stomach. Krukenberg tumors mostly occur after 40 years. Metastatic ovarian tumors in young age are very rare. Here, we reported a very rare case of bilateral Krukenberg tumors of the ovaries arising from a primary adenocarcinoma of the stomach in a 20 year old Indian female.
APA, Harvard, Vancouver, ISO, and other styles
12

Misao, Ryou, Yoshihito Nakanishi, Jiro Fujimoto, Masashi Hori, Satoshi Ichigo, and Teruhiko Tamaya. "Expression of sex hormone-binding globulin mRNA in human ovarian cancers." European Journal of Endocrinology 133, no. 3 (1995): 327–34. http://dx.doi.org/10.1530/eje.0.1330327.

Full text
Abstract:
Misao R, Nakanishi Y, Fujimoto J. Hori M, Ichigo S, Tamaya T. Expression of sex hormone-binding globulin mRNA in human ovarian cancers. Eur J Endocrinol 1995;133:327–34. ISSN 0804–4643 To know the role of sex hormone-binding globulin (SHBG) in the intracellular steroidal actions in human ovarian cancers, the expression of SHBG mRNA as a substitute for intracellular SHBG expression was investigated in normal ovarian tissues and ovarian tumors. In the present study, we used competitive reverse transcription–polymerase chain reaction–Southern blot analysis to evaluate SHBG mRNA levels. The expres
APA, Harvard, Vancouver, ISO, and other styles
13

Pannu, Harpreet K., Weining Ma, Emily Craig Zabor, Chaya S. Moskowitz, Richard R. Barakat, and Hedvig Hricak. "Enhancement of Ovarian Malignancy on Clinical Contrast Enhanced MRI Studies." ISRN Obstetrics and Gynecology 2013 (February 13, 2013): 1–8. http://dx.doi.org/10.1155/2013/979345.

Full text
Abstract:
Purpose. To assess if there is a significant difference in enhancement of high grade serous carcinoma of the ovary compared with other ovarian malignancies on clinically performed contrast enhanced MRI studies. Methods. In this institutional-review–board-approved study, two radiologists reviewed contrast enhanced MRI scans in 37 patients with ovarian cancer. Readers measured the signal intensity (SI) of ovarian mass and gluteal fat pre- and postcontrast administration. Percentage enhancement (PE) was calculated as [(post-pre)/precontrast SI] × 100. Results. Pathology revealed 19 patients with
APA, Harvard, Vancouver, ISO, and other styles
14

Kudla, Marek Jerzy, Michal Zikan, Daniela Fischerova, Mateusz Stolecki, and Juan Luis Alcazar. "4D Doppler Ultrasound in High Grade Serous Ovarian Cancer Vascularity Evaluation—Preliminary Study." Diagnostics 11, no. 4 (2021): 582. http://dx.doi.org/10.3390/diagnostics11040582.

Full text
Abstract:
The aim of the study was to evaluate the usefulness of 4D Power Doppler tissue evaluation to discriminate between normal ovaries and ovarian cancer tumors. This was a prospective observational study. Twenty-three cases of surgically confirmed ovarian High Grade Serous Carcinoma (HGSC) were analyzed. The control group consisted of 23 healthy patients, each matching their study-group counterpart age wise (±3 years) and according to their menopausal status. Transvaginal Doppler 4D ultrasound scans were done on every patient and analyzed with 3D/4D software. Two 4D indices—volumetric Systolic/Dias
APA, Harvard, Vancouver, ISO, and other styles
15

Kravtsova, Oksana E., Galina Andreevna Nerodo, Vera P. Nikitina, Ekaterina V. Verenikina, Ivan Nikitin, and Alla V. Pustovalova. "Lipid peroxidation in tissues of ovarian tumors after neoadjuvant chemotherapy." Journal of Clinical Oncology 35, no. 15_suppl (2017): e17036-e17036. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e17036.

Full text
Abstract:
e17036 Background: The purpose of the study was to analyze neoadjuvant chemotherapy (NACT) effect on parameters of monoaminergic, free radical and hydrolytic systems in tissues of malignant ovarian tumors. Methods: Activity of parameters of monoaminergic, free radical and hydrolytic systems was determined in ovarian tissue of 92 patients with ovarian cancer. Tissues of tumorous and contralateral (non-tumorous) ovaries were studied, and results were compared to the data in 30 patients with uterine fibroids and other benign tumors. Results: Tumorous ovaries showed the decrease in vitamins E and
APA, Harvard, Vancouver, ISO, and other styles
16

Spiridonova, N. V., A. A. Demura, and V. Yu Schukin. "Evaluation of concomitant gynecological pathology in group of patients of reproductive age with tumors and tumor formations." Medical alphabet, no. 16 (September 21, 2020): 10–14. http://dx.doi.org/10.33667/2078-5631-2020-16-10-14.

Full text
Abstract:
According to modern literature, the frequency of preoperative diagnostic errors for tumour-like formations is 30.9–45.6%, for malignant ovarian tumors is 25.0–51.0%. The complexity of this situation is asymptomatic tumor in the ovaries and failure to identify a neoplastic process, which is especially important for young women, as well as ease the transition of tumors from one category to another (evolution of the tumor) and the source of the aggressive behavior of the tumor. The purpose of our study was to evaluate the history of concomitant gynecological pathology in a group of patients of re
APA, Harvard, Vancouver, ISO, and other styles
17

Yang, Guofen, Weipeng He, Muyan Cai, et al. "Loss/Down-Regulation of Tumor Suppressor in Lung Cancer 1 Expression Is Associated With Tumor Progression and Is a Biomarker of Poor Prognosis in Ovarian Carcinoma." International Journal of Gynecologic Cancer 21, no. 3 (2011): 486–93. http://dx.doi.org/10.1097/igc.0b013e31820fa168.

Full text
Abstract:
ObjectivesThe tumor suppressor in lung cancer 1 (TSLC1) has been identified as a putative tumor suppressor gene in non-small cell lung cancer. Although loss of TSLC1 has been observed in a number of human malignancies, the expression levels of TSLC1 gene in ovarian cancer and its clinical or prognostic significance have not been investigated.MethodsProtein expression levels of TSLC1 was explored by semiquantitative immunohistochemical staining on archival formalin-fixed, paraffin-embedded pathological specimen consisting of 30 normal ovaries, 30 ovarian cystadenomas, 40 borderline ovarian tumo
APA, Harvard, Vancouver, ISO, and other styles
18

Kappus, Natalie, Oday Karadsheh, Dhammi K. K. Jayathilaka, and Paresh Dandona. "The Story of a Radiologically Undetectable, Testosterone Producing Leydig Cell Tumor." Journal of the Endocrine Society 5, Supplement_1 (2021): A1041—A1042. http://dx.doi.org/10.1210/jendso/bvab048.2131.

Full text
Abstract:
Abstract Introduction: Leydig stromal cell tumors are uncommon ovarian tumors that produce testosterone leading to hyperandrogenism. We present a case of a 63 year old lady with significantly elevated testosterone levels that did not have clear ovaries visualized on imaging, but was subsequently found to have a Leydig cell tumor on pathology after ovarian resection. Clinical Case: A 63 year old female with a past medical history of COPD, hypothyroidism, hyperlipidemia, hypertension and uterine fibroids status post hysterectomy and left oophorectomy in 1995 was referred to endocrinology for hir
APA, Harvard, Vancouver, ISO, and other styles
19

Mamedova, S. M., M. A. Qarashova, E. M. Aliyeva, and S. Q. Sultanova. "The condition of the hypothalamic-pituitary-adrenal-ovarian system in women with tumors and tumoral formations of the organs of the reproductive system in the postmenopausal period." HEALTH OF WOMAN, no. 7(133) (September 30, 2018): 96–99. http://dx.doi.org/10.15574/hw.2018.133.96.

Full text
Abstract:
The objective: of the study was to study the state of the hypothalamic-pituitary-adrenal-ovarian system in women with benign preinvasive and tumor-like formations of the reproductive system organs in the postmenopausal period. Materials and methods. 130 women with various tumors and tumoral formations of reproductive system organs in the postmenopausal period were examined. The parameters of follicle stimulating, luteinizing hormones, estradiol, estrone, prolactin, progesterone, testosterone, dehydroepiandosterone sulfate were studied. Results. It was established that out of 130 women with var
APA, Harvard, Vancouver, ISO, and other styles
20

Barua, Animesh, Aparna Yellapa, Salvatore A. Grasso, et al. "Expression of glucose-regulated protein 78 (GRP78) and its regulator microrna-181 during the development and progression of ovarian cancer." Journal of Clinical Oncology 31, no. 15_suppl (2013): 5579. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.5579.

Full text
Abstract:
5579 Background: Ovarian cancer (OVCA) is a lethal malignancy of women with a distinct pattern of metastasis through peritoneal dissemination. Sustained exposure of the ovaries to oxidative stress due to inflammatory processes including ovulatory genotoxicity, makes the ovarian microenvironment conducive to malignant cell proliferation. GRP78 is a stress-inducible protein which resides in the endoplasmic reticulum of the cell. Thus GRP78 may be a marker of ovarian tumor associated stress and could represent a therapeutic target for OVCA. The goal of this study was to examine if GRP78 expressio
APA, Harvard, Vancouver, ISO, and other styles
21

Paul, P. G., Anjana Annal, K. Anusha Chowdary, George Paul, and Manali Shilotri. "A case benign struma ovarii." International Journal of Reproduction, Contraception, Obstetrics and Gynecology 10, no. 3 (2021): 1224. http://dx.doi.org/10.18203/2320-1770.ijrcog20210769.

Full text
Abstract:
Struma ovarii is a rare ovarian tumor and a monodermal variant of dermoid tumors of the ovary in which thyroid tissue components constitute more than 50% of the mass. Struma ovarii accounts for 0.5–1.0% of all ovarian tumors and 2-5% of ovarian teratomas. Most cases are benign, but malignant transformation is found in a small percentage. It usually presents as a unilateral adnexal mass at fifth and sixth decades of life, with symptoms like other ovarian tumors. The definitive diagnosis is made by histological examination. Adnexectomy remains the standard line of treatment for benign disease. A
APA, Harvard, Vancouver, ISO, and other styles
22

Mileo, A. M., M. Fanuele, F. Battaglia, et al. "Preliminary evaluation of HER-2/neu oncogene and epidermal growth factor receptor expression in normal and neoplastic human ovaries." International Journal of Biological Markers 7, no. 1 (1992): 47–51. http://dx.doi.org/10.1177/172460089200700107.

Full text
Abstract:
The HER-2/neu oncogene (a member of the Erb-like oncogene family) is distinct from but closely related to the c-erb B gene which encodes the epidermal growth factor receptor (EGFr). HER-2/neu gene amplification was found in a large number of mammary carcinomas and there was a strong correlation between this phenomenon and poor prognosis. In our study HER-2/neu oncogene expression was determined in 16 malignant ovarian tumors, 2 ovarian lymphomas and 5 normal ovaries. The HER-2/neu gene was found both in normal ovaries and malignant tumors, without any apparent difference among the various hist
APA, Harvard, Vancouver, ISO, and other styles
23

Mileo, A. M., M. Fanuele, F. Battaglia, et al. "Preliminary evaluation of HER-2/neu oncogene and epidermal growth factor receptor expression in normal and neoplastic human ovaries." International Journal of Biological Markers 7, no. 2 (1992): 114–18. http://dx.doi.org/10.1177/172460089200700208.

Full text
Abstract:
The HER-2/neu oncogene (a member of the Erb-like oncogene family) is distinct from but closely related to the c-erb B gene which encodes the epidermal growth factor receptor (EGFr). HER-2/neu gene amplification was found in a large number of mammary carcinomas and there was a strong correlation between this phenomenon and poor prognosis. In our study HER-2/neu oncogene expression was determined in 16 malignant ovarian tumors, 2 ovarian lymphomas and 5 normal ovaries. The HER-2/neu gene was found both in normal ovaries and malignant tumors, without any apparent difference among the various hist
APA, Harvard, Vancouver, ISO, and other styles
24

ŠIMAGA, Š., M. Osmak, D. Babič, M. ŠPREM, B. Vukelič, and M. Abramič. "Quantitative biochemical analysis of lactate dehydrogenase in human ovarian tissues: correlation with tumor grade." International Journal of Gynecologic Cancer 15, no. 3 (2005): 438–44. http://dx.doi.org/10.1136/ijgc-00009577-200505000-00005.

Full text
Abstract:
In an attempt to identify glycolytic capacity of normal and neoplastic human ovary, total lactate dehydrogenase (LDH) activity was measured in tissue cytosol originating from 69 patients (18 with benign ovarian tumor, 34 with ovarian carcinoma, six with nonepithelial ovarian malignant tumors, and 11 with tumor metastatic to ovary) and compared to the LDH activity of normal ovarian tissues (n = 19). Median value of total LDH-specific activity expressed as U/mg protein was 0.546 in normal tissues, 0.584 in benign tumors, 1.071 in malignancies metastatic to ovaries, 0.872 in nonepithelial primary
APA, Harvard, Vancouver, ISO, and other styles
25

Rusda, Muhammad, Riza Rivany, Citra Lestari Hasibuan, Delfi Lutan, Dudy Aldiansyah, and Cut Adeya Adella. "IHC Expression Relationships MMP7 and VEGF With Normal Ovaries and Ovarian Pathologies." Sumatera Medical Journal 2, no. 1 (2019): 47–54. http://dx.doi.org/10.32734/sumej.v2i1.719.

Full text
Abstract:
To investigate the association of MMP7 and VEGF expression with ovarian cancer, benign ovarian cysts, and normal ovaries. This study was analytical research with case-control design. In the study, IHC expression of MMP7 and VEGF was carried out on paraffin block of ovarian cancer tissue, benign ovarian cyst, and normal ovary. In 40 subjects with ovarian tumors, 17 patients were found with positive MMP7 expression. In the control group, no subjects were found with positive MMP7 expression. There was a significant relationship between MMP7 expression and ovarian tumor incidence. Meanwhile, in 40
APA, Harvard, Vancouver, ISO, and other styles
26

Demina, D. V., and V. V. Vustenko. "CLINICAL EFFECTIVENESS OF THERAPEUTIC AND PROPHYLACTIC MEASURES IN PREGNANT WOMEN WITH OPERATED OVARIES IN HYPERHOMOCYSTEINEMIA." Journal of Volgograd State Medical University 76, no. 4 (2020): 114–16. http://dx.doi.org/10.19163/1994-9480-2020-4(76)-114-116.

Full text
Abstract:
According to the literature, women with a history of ovarian surgery have reproductive health problems not only during the planning stage of pregnancy, but also during the gestational period. The aim of the study was to reduce the frequency of obstetric complications in pregnant women with operated ovaries with hyperhomocysteinemia by developing a scheme of therapeutic and preventive measures. The study included 117 pregnant women with surgical interventions for benign ovarian tumors/ovarian tumors in the presence of hyperhomocysteinemia, of which 60-the developed scheme was used (group E1) an
APA, Harvard, Vancouver, ISO, and other styles
27

Muratov, A. A. "On the issue of bleeding into the cavity of the ovarian dermoid during uterine pregnancy, simulating rupture of the fetuses in the ovary during ectopic pregnancy." Journal of obstetrics and women's diseases 9, no. 7-8 (2020): 603–15. http://dx.doi.org/10.17816/jowd97-8603-615.

Full text
Abstract:
Tumors of the ovaries in general and dermoids in particular do not particularly complicate a normal pregnancy, causing the last more or less inconvenience.All ovarian tumors, with the exception of dermoid tumors, differing in relatively large sizes, generally speaking and with the exception of very bulky tumors, lessen the development of pregnancy and especially the course of labor, since these tumors have a tendency to grow upward into the abdominal cavity, thus being removed from small pelvis.
APA, Harvard, Vancouver, ISO, and other styles
28

FERRANDINA, G., G. BONANNO, L. PIERELLI, et al. "Expression of CD133-1 and CD133-2 in ovarian cancer." International Journal of Gynecologic Cancer 18, no. 3 (2008): 506–14. http://dx.doi.org/10.1111/j.1525-1438.2007.01056.x.

Full text
Abstract:
Cancer stem cells have been isolated from several solid tumors including prostate, colon, liver, breast, and ovarian cancer. Stem cells isolated from nervous system and prostate express CD133 antigen, which is widely used to isolate hematopoietic stem and progenitor cells. The aims of this study were to investigate the expression of the CD133-1 and CD133-2 epitopes in primary ovarian tumors and to biologically characterize CD133+ovarian cancer cells, also according to clinicopathologic parameters. Tissue specimens were obtained at primary surgery from 41 ovarian carcinomas; eight normal ovarie
APA, Harvard, Vancouver, ISO, and other styles
29

Khunamornpong, S., P. Suprasert, W. Na Chiangmai, and S. Siriaunkgul. "Metastatic tumors to the ovaries: a study of 170 cases in northern Thailand." International Journal of Gynecologic Cancer 16, Suppl 1 (2006): 132–38. http://dx.doi.org/10.1136/ijgc-00009577-200602001-00022.

Full text
Abstract:
The cases of malignant ovarian tumors treated at Chiang Mai University hospital between 1992 and 2003 were histologically reviewed. The medical records, the radiologic findings, and the follow-up outcome in the cases suspicious or diagnostic of metastases were reviewed to confirm the diagnosis and to determine the primary sites. Metastatic tumors accounted for 30% of malignant ovarian tumors. A total of 170 cases of metastatic tumors included 117 cases with nongynecologic origin and 53 cases with gynecologic origin. Nongynecologic metastatic tumors were from large intestine (31%), stomach (14%
APA, Harvard, Vancouver, ISO, and other styles
30

Makhlouf, A. M., M. M. Fathalla, M. A. Zakhary, and M. H. Makarem. "Sulfatides in ovarian tumors: clinicopathological correlates." International Journal of Gynecologic Cancer 14, no. 1 (2004): 89–93. http://dx.doi.org/10.1136/ijgc-00009577-200401000-00011.

Full text
Abstract:
ObjectivesTo investigate the expression of sulfatides in the tissue homogenates of malignant ovarian tumors, benign ovarian tumors, and control tissues and to study the relation between this marker and other clinico-pathological criteria such as the tumor type, grade of differentiation, surgical stage and ovulatory years.DesignCross-sectional study.SettingDepartment of Obstetrics and Gynecology and Department of Biochemistry, Assuit university hospital.SubjectsForty-six patients had malignant ovarian tumors. Sixteen patients had benign ovarian neoplasm. Thirty patients, with normal ovaries, re
APA, Harvard, Vancouver, ISO, and other styles
31

Novikova, Inna Arnoldovna, Galina Nerodo, and Anna Iurievna Mordan. "Comparative analysis of DNA-cytometric indices of primary and relapsing ovarian cencer." Journal of Clinical Oncology 31, no. 15_suppl (2013): e16558-e16558. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e16558.

Full text
Abstract:
e16558 Background: A ploidy of an average grade of aneuploidy cells and of proliferation index in ovarian tumor was studied. Methods: 21 patients with ovarian cancer of III-IV grades and 12 patients with acknowledged relapse of the disease aged from 46 to 67 to part in the research. We used CycleTEST PLUS DNA Reagent Kit (Becton Dickinson) for the analysis of DNA in the tumor’s tissues. Preparation of the tumor’s tissues was made with the use of disaggregating device BD Medimachine; after painting with propidium iodide (PI) we analyzed at flow cytofluorimeter BD Facs CantooII. Received data wa
APA, Harvard, Vancouver, ISO, and other styles
32

Marinkovic, Darko, Nebojsa Pavlovic, Vladimir Magas, and Sanja Aleksic-Kovacevic. "Pathohistological study of tumors in canine testes and ovarian in the period 1999-2003." Veterinarski glasnik 60, no. 1-2 (2006): 51–60. http://dx.doi.org/10.2298/vetgl0602051m.

Full text
Abstract:
Testes and ovarian tumors are tumors which appear in small percentages in dogs. They rarely lead to a lethal outcome in animals, but, due to the different clinical manifestations that can accompany these tumors, their timely diagnosis is significant because it often determines the treatment of the animal in which such tumors were diagnosed. During the period from 1999 until 2003, the Department for Pathological Morphology of the Belgrade Faculty of Veterinary Medicine examined macroscopically and pathohistologically 5 ovaries with macroscopic signs of neoplastic changes from 5 female and 25 ne
APA, Harvard, Vancouver, ISO, and other styles
33

Yamanishi, Yukio, Masafumi Koshiyama, Megumi Ohnaka, et al. "Pathways of Metastases from Primary Organs to the Ovaries." Obstetrics and Gynecology International 2011 (2011): 1–6. http://dx.doi.org/10.1155/2011/612817.

Full text
Abstract:
To investigate the metastatic pathways from the primary organs to the ovaries, we examined the microscopic findings from 18 original and 18 metastatic ovarian tumors carefully. In addition, we examined the immunohistochemical findings (Victoria blue stain for vascular invasion and D2-40 expression for lymphangio invasion) of metastatic ovarian tumors carefully. There were 4 (57%) ovarian lymphangio invasion cases in the 7 gastric cancers, but there were no cases in the 6 colorectal cancers (P< 0.05). There were 4 (67%) ovarian vascular invasion cases and one (17%) liver metastasis case in t
APA, Harvard, Vancouver, ISO, and other styles
34

Lyubimova, N. V., A. M. Beishembaev, Yu S. Timofeev, and N. E. Kushlinskii. "Inhibin B in stromal-cell ovarian tumors." Advances in Molecular Oncology 7, no. 1 (2020): 32–37. http://dx.doi.org/10.17650/2313-805x-2020-7-1-32-37.

Full text
Abstract:
Background. Tumors of stroma of the sex cord include a family of tumors that are diverse in structure and biological characteristics, including hormone-active ovarian tumors, such as granulosa cell tumor (GCT) of the ovary and a tumor from Sertoli–Leydig cells. For these types of tumors, of particular importance is the analysis of biochemical markers, among which the most promising is inhibin B.The objective of the study. Comparative analysis of inhibin B levels in the blood serum of patients with stromal cell tumors and other types malignancies.Materials and methods. 64 patients with primary
APA, Harvard, Vancouver, ISO, and other styles
35

Kriplani, Divya, and Mandakini M. Patel. "Immunohistochemistry: A diagnostic aid in differentiating primary epithelial ovarian tumors and tumors metastatic to the ovary." South Asian Journal of Cancer 02, no. 04 (2013): 254–58. http://dx.doi.org/10.4103/2278-330x.119888.

Full text
Abstract:
Abstract Introduction: Among cancers of the female genital tract, the incidence of ovarian cancer ranks below only carcinoma of the cervix and the endometrium. Recent years have witnessed significant development in the use of immunohistochemistry in diagnostic ovarian pathology. Materials and Methods: We received 95 specimens and biopsies of primary ovarian neoplasms and neoplasms metastatic to the ovary in a period of 2 years. Of these 30 cases were of the primary surface epithelial neoplasms and seven of metastatic tumors. Discussion: The most common tumors metastasizing to the ovary origina
APA, Harvard, Vancouver, ISO, and other styles
36

Kaur, Sarbhjit, Vijay Kumar Bodal, Manjit Singh Bal, Ranjeev Bhagat, Nishit Gupta, and Dimpi Ohari. "Hyperthyroidism with Struma Ovarii." International Journal of Medical and Dental Sciences 3, no. 1 (2014): 344. http://dx.doi.org/10.19056/ijmdsjssmes/2014/v3i1/80707.

Full text
Abstract:
<p>Struma ovarii or monodermal teratoma, is a specialized ovarian neoplasm composed entirely of mature thyroid tissue. It is a relatively rare tumor which comprises 1% of all ovarian tumors and 2.7% of all dermoid tumors. Its colour and consistency is like that of a thyroid tissue. The tissue may show any of the pathologic changes seen in a normally placed gland, including diffuse or nodular hyperplasia, thyroiditis, papillary carcinoma, follicular carcinoma and malignant lymphoma.</p><p>We reported a case of hyperthyroidism with struma ovarii. A 70 year old female was operat
APA, Harvard, Vancouver, ISO, and other styles
37

Pérez-Ortiz, Viorkis, and Eduardo Reyna-Villasmil. "Tumor maligno mixto de células germinales de ovario. Reporte de caso." Revista Peruana de Ginecología y Obstetricia 66, no. 1 (2020): 107–11. http://dx.doi.org/10.31403/rpgo.v66i2241.

Full text
Abstract:
Los tumores malignos de células germinales del ovario, aunque poco frecuentes, son el tipo más común de neoplasias ováricas malignas en niñas y adolescentes; aproximadamente dos tercios de ellas menores de 20 años. Representan 2% a 5% de todos los tumores ováricos de origen germinal. Los tumores comprenden dos o más tipos de componentes de células germinales, e incluyen al disgerminoma acompañado de tumores del seno endodérmico, carcinoma de células embrionarias, teratoma maduro o inmaduro y/o coriocarcinoma. Existen pocos informes de casos de tumores de células germinales mixtas con diferente
APA, Harvard, Vancouver, ISO, and other styles
38

Roberts, Patrick, Sharon Nofech-Mozes, Natalie Coburn, Paul Hamilton, and Lilian T. Gien. "Retroperitoneal Extraovarian Fibrothecoma Mimicking a Malignant Epithelial Ovarian Carcinoma." Case Reports in Obstetrics and Gynecology 2012 (2012): 1–5. http://dx.doi.org/10.1155/2012/281745.

Full text
Abstract:
Background. Fibrothecomas are benign sex cord-stromal tumors which rarely originate outside of the ovary. To date, two such cases have been reported in the literature. We report the third case of an extraovarian fibrothecoma and the first presenting similarly to a metastatic epithelial ovarian cancer.Clinical History. We describe a 62-year-old woman with history, physical examination, and imaging suggestive of metastatic ovarian cancer. CA-125 was elevated at 1291 U/mL. Paracenteses were negative for malignant cells and core biopsy showed spindle cell proliferation. A primary debulking surgery
APA, Harvard, Vancouver, ISO, and other styles
39

_, _. "Ovarian Cancer." Journal of the National Comprehensive Cancer Network 6, no. 8 (2008): 766. http://dx.doi.org/10.6004/jnccn.2008.0058.

Full text
Abstract:
Epithelial ovarian cancer is the leading cause of death from gynecologic cancer and the fifth most common cause of cancer mortality in women in the United States. Fewer than 40% of women with ovarian cancer are cured, and 70% of patients present with advanced disease; because of the location of the ovaries, ovarian cancer has been difficult to diagnose at earlier stages. Epidemiologic studies have identified risk factors, including family history. The NCCN guidelines discuss epithelial ovarian cancer as well as less common ovarian histopathologies, including germ cell neoplasms, carcinosarcoma
APA, Harvard, Vancouver, ISO, and other styles
40

Miao, Yali, Jirui Wen, Liwei Huang, Jiang Wu, and Zhiwei Zhao. "Diagnosis and Management of Ovarian Tumor in Mayer-Rokitansky-Küster-Hauser (MRKH) Syndrome." BioMed Research International 2018 (2018): 1–6. http://dx.doi.org/10.1155/2018/2369430.

Full text
Abstract:
In the most recent publications on Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome, the uterine remnants and ovaries in patients may develop uterine remnant leiomyoma, adenomyosis, or ovarian tumor, and this can lead to problems in differential diagnosis. Here we summarize the diagnosis methods and available interventions for ovarian tumor in MRKH syndrome, with emphasis on the relevant clinical findings and illustrative relevant case. According to the clinical findings and illustrative relevant case, with the help of imaging techniques, ovarian tumors can be detected in the pelvis in patients
APA, Harvard, Vancouver, ISO, and other styles
41

Kolak, Agnieszka, Michal Lozinski, and Slawomir Mandziuk. "Systemic treatment of Krukenberg tumors." Current Issues in Pharmacy and Medical Sciences 30, no. 4 (2017): 180–83. http://dx.doi.org/10.1515/cipms-2017-0033.

Full text
Abstract:
Abstract Of all ovarian tumors with distinct biological features, 10-25% are secondary ovarian tumors. Among the most common cancers that cause ovarian metastasis are breast cancer, colorectal cancer, endometrium, as well as gastric and lateral cancer. Krukenberg tumors remain asymptomatic until the tumor reaches a certain size, as in the case of primary ovarian cancer. Symptoms are non-specific: abdominal pain (42%), postmenopausal bleeding (18%), weight loss (6%) and an increasing abdominal girth (15%). Diagnostic procedures should include physical examination, basic blood and biochemistry t
APA, Harvard, Vancouver, ISO, and other styles
42

Kobaidze, Ekaterina G., and Yu A. Shashurina. "Obstetric and gynecological anamnesis in postmenopausal women with ovarian tumors." Perm Medical Journal 37, no. 5 (2021): 35–42. http://dx.doi.org/10.17816/pmj37535-42.

Full text
Abstract:
Relevance. Etiology, prevention and treatment of ovarian tumors in postmenopausal patients is an actual scientific issue.
 Materials and methods. The paper presents the data of obstetric and gynecological anamnesis, obtained in retrospective study of case histories of postmenopausal patients with benign ovarian tumors (n = 120);
 The data regarding patients basic complaints are given, the period from the moment of addressing for medical aid to the moment of surgical treatment was analyzed.
 Results. The study results showed that ovarian tumors were predominantly diagnosed in pat
APA, Harvard, Vancouver, ISO, and other styles
43

Kobaidze, Ekaterina G., and Yu A. Shashurina. "Obstetric and gynecological anamnesis in postmenopausal women with ovarian tumors." Perm Medical Journal 37, no. 5 (2021): 35–42. http://dx.doi.org/10.17816/pmj37535-42.

Full text
Abstract:
Relevance. Etiology, prevention and treatment of ovarian tumors in postmenopausal patients is an actual scientific issue.
 Materials and methods. The paper presents the data of obstetric and gynecological anamnesis, obtained in retrospective study of case histories of postmenopausal patients with benign ovarian tumors (n = 120);
 The data regarding patients basic complaints are given, the period from the moment of addressing for medical aid to the moment of surgical treatment was analyzed.
 Results. The study results showed that ovarian tumors were predominantly diagnosed in pat
APA, Harvard, Vancouver, ISO, and other styles
44

Gusain, Poonam, Suniti Joshi Rawal, and Sharma Paudel. "Correlation of Sonographic Morphologic Index and CA-125 in Predicting the Nature of Ovarian Tumor." Journal of Karnali Academy of Health Sciences 2, no. 3 (2019): 166–70. http://dx.doi.org/10.3126/jkahs.v2i3.26643.

Full text
Abstract:
Introduction: Ovarian tumor is a group of diseases that originates in the ovaries or in the related areas of the fallopian tubes and the peritoneum. Ovarian cancer causes more deaths than any other cancer of the female reproductive system. This study was undertaken to evaluate the efficacy of Sonographic Morphology Index (MI) and CA-125 levels in predicting malignancy in patients with ovarian tumors.
 Methods: This study was conducted between April 2016 and April 2017 in the Department of Obstetrics and Gynaecology and Radiology of Tribhuvan University Teaching Hospital. During this perio
APA, Harvard, Vancouver, ISO, and other styles
45

Perlman, S., A. Ben-Arie, E. Feldberg, and Z. Hagay. "Non-Hodgkin's lymphoma presenting as advanced ovarian cancer—a case report and review of literature." International Journal of Gynecologic Cancer 15, no. 3 (2005): 554–57. http://dx.doi.org/10.1136/ijgc-00009577-200505000-00023.

Full text
Abstract:
Non-Hodgkin's lymphoma involving the ovaries is unusual and may cause confusion for the clinician since its presentation might resemble other, much more frequent tumors. Malignant lymphoid cells may occur in the ovary either as a primary neoplasm or as a secondary manifestation of a disseminated occult or known disease. The most common presenting signs or symptoms of malignant lymphomas involving the ovaries are abdominal or pelvic pain or mass. We present here a unique case of non-Hodgkin's lymphoma involving the ovaries presenting as advanced ovarian cancer with a pelvic mass, pleural effusi
APA, Harvard, Vancouver, ISO, and other styles
46

Ramu, Shwetha, and Ruchi Sinha. "Significance of Thrombocytosis in Epithelial Ovarian Tumors." International Journal of Life-Sciences Scientific Research 3, no. 6 (2017): 1467–70. http://dx.doi.org/10.21276/ijlssr.2017.3.6.7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Jandial, Roopali, and Ritu Bhagat. "Diversity of Ovarian Tumors An Institutional Study." Asian Pacific Journal of Health Sciences 6, no. 2 (2019): 78–82. http://dx.doi.org/10.21276/apjhs.2019.6.2.10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Salinas Salinas, Vicente Anibal, Gabriela Yulissa Fajardo Ponce, Julian Alfonso Luna Montalván, Victoria Samanta Luna Panimboza, Juan Alfredo Ramírez Pico, and Andy Michael Moreno Espinoza. "Tumores Benignos de Ovario en la edad Pediátrica y Adolescencia." Oncología (Ecuador) 29, no. 2 (2019): 110–18. http://dx.doi.org/10.33821/86.

Full text
Abstract:
Introducción: Los tumores ováricos son raros en la edad pediátrica y representan del 1 al 5% de los tumores infantiles. El objetivo del presente trabajo es conocer cuáles son los tumores de ovario más frecuentes en nuestro medio en niñas y adolescentes en un centro oncológico de la ciudad de Guayaquil-Ecuador.
 Métodos: El presente estudio es descriptivo y retrospectivo, en la que se realiza una revisión de registros de niñas y adolescentes con diagnóstico de tumores de ovario, en el Instituto Oncológico Nacional “Dr. Juan Tanca Marengo” en el período de enero 2015 a mayo del 2017. Las va
APA, Harvard, Vancouver, ISO, and other styles
49

Buckanovich, Ronald J., Dimitra Sasaroli, Anne O'Brien-Jenkins, et al. "Tumor Vascular Proteins As Biomarkers in Ovarian Cancer." Journal of Clinical Oncology 25, no. 7 (2007): 852–61. http://dx.doi.org/10.1200/jco.2006.08.8583.

Full text
Abstract:
Purpose This study aimed to identify novel ovarian cancer biomarkers and potential therapeutic targets through molecular analysis of tumor vascular cells. Methods Immunohistochemistry-guided laser-capture microdissection and genome-wide transcriptional profiling were used to identify genes that were differentially expressed between vascular cells from human epithelial ovarian cancer and healthy ovaries. Tumor vascular markers (TVMs) were validated through quantitative real-time polymerase chain reaction (qRT-PCR) of immunopurified tumor endothelial cells, in situ hybridization, immunohistochem
APA, Harvard, Vancouver, ISO, and other styles
50

Lavie, Ofer, Teri Longacre, Yakir Segev, and Amreen Husain. "Ovarian Carcinosarcomas Associated With Prolonged Use of Tamoxifen: Case Reports." International Journal of Gynecologic Cancer 19, no. 9 (2009): 1521–23. http://dx.doi.org/10.1111/igc.0b013e3181a83fbf.

Full text
Abstract:
Background:Recent studies have indicated that the risk associated with tamoxifen may be substantially higher for uterine malignant mixed müllerian tumors and uterine sarcomas.Case:We present 2 cases of ovarian carcinosarcomas in patients with a personal history of breast carcinoma who were treated for a prolonged period with tamoxifen.Conclusions:To our knowledge, these 2 cases are the first to describe the possible association between ovarian carcinosarcomas and previous personal and familial history of breast carcinoma and\or prolonged use of tamoxifen. These cases may suggest that like in t
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!